| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00997243 |
| P698 | PubMed publication ID | 7698150 |
| P50 | author | Francesco Trotta | Q118517111 |
| Giovanni Lucignani | Q43107268 | ||
| P2093 | author name string | M R Tola | |
| A Piffanelli | |||
| M Giganti | |||
| C Cittanti | |||
| P Colamussi | |||
| R Tamarozzi | |||
| L Dovigo | |||
| P2860 | cites work | Initial experience with 99m Tc-hexamethyl-propylene amine oxime (HM-PAO) single photon emission computed tomography (SPECT) in patients with focal epilepsy | Q70412990 |
| The neurological manifestations of systemic lupus erythematosus | Q70861096 | ||
| Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography | Q72023288 | ||
| Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus | Q72547403 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 | ||
| Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. | Q33451037 | ||
| Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. | Q33470628 | ||
| Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease | Q33490122 | ||
| SPECT, MRI and cognitive functions in multiple sclerosis | Q33589282 | ||
| Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus | Q33592040 | ||
| Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement | Q33629959 | ||
| Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus | Q39485237 | ||
| Diagnosis of central nervous system lupus | Q39551293 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. | Q40971202 | ||
| Association of IgG Anti-Brain Antibodies with Central Nervous System Dysfunction in Systemic Lupus Erythematosus | Q41045161 | ||
| Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis | Q43918124 | ||
| A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia | Q44035645 | ||
| Focal high uptake of HM-PAO in brain perfusion studies: a clue in the diagnosis of encephalitis | Q44622896 | ||
| Brain pathology in systemic lupus erythematosus | Q45055245 | ||
| Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus | Q46909297 | ||
| Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning | Q48115666 | ||
| Cerebral involvement in systemic lupus erythematosus | Q48139419 | ||
| MRI and SPECT investigations of the CNS in SLE patients. | Q48356137 | ||
| A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease | Q48466597 | ||
| Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus | Q48473651 | ||
| MR imaging of systemic lupus erythematosus involving the brain | Q48493240 | ||
| HMPAO-SPECT and MRI in acute disseminated encephalomyelitis | Q48643172 | ||
| The selective value of computed tomography of the brain in cerebritis due to systemic lupus erythematosus. | Q48875431 | ||
| The pathogenesis of central nervous system manifestations of systemic lupus erythematosus | Q48925433 | ||
| Positron emission tomography in neuropsychiatric lupus erythematosus | Q49124199 | ||
| I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study | Q67482147 | ||
| Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease | Q68097061 | ||
| Cerebral blood flow variations in CNS lupus | Q68694958 | ||
| Neuropsychiatric manifestations of systemic lupus erythematosus | Q69078451 | ||
| Central nervous system involvement in systemic lupus erythematosus. A study of 150 cases | Q69974591 | ||
| P433 | issue | 1 | |
| P921 | main subject | neuropsychiatric systemic lupus erythematosus | Q9358981 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 17-24 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
| P1476 | title | Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations | |
| P478 | volume | 22 |
| Q71814762 | 18FDG PET and acetazolamide-enhanced99mTc-HMPAO SPET in systemic lupus erythematosus |
| Q34017192 | A pattern of cerebral perfusion anomalies between major depressive disorder and Hashimoto thyroiditis. |
| Q49026833 | Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosus |
| Q48466057 | Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus |
| Q21260341 | Behaviour sequelae following acute Kawasaki disease |
| Q45004500 | Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis |
| Q48280000 | Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations |
| Q44687451 | Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage |
| Q44568826 | Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy |
| Q48299120 | Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings |
| Q33217667 | Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice |
| Q51682014 | Epileptic seizures and EEG features in juvenile systemic lupus erythematosus. |
| Q53576675 | Evaluation of average amount of cerebral blood flow measured by brain perfusion index in patients with neuropsychiatric systemic lupus erythematosus. |
| Q44698496 | In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). |
| Q31942717 | Internuclear ophthalmoplegia in systemic lupus erythematosus |
| Q48391957 | Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. |
| Q33753228 | Neuroimaging in neuropsychiatric systemic lupus erythematosus |
| Q36707992 | Neuroimmunopathology in a murine model of neuropsychiatric lupus |
| Q40149699 | Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus |
| Q48437120 | Parkinsonian syndrome complicating systemic lupus erythematosus |
| Q35126686 | Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. |
| Q35555754 | Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. |
| Q73614173 | Raynaud's syndrome in systemic lupus erythematosus |
| Q48093561 | Regional cerebral blood flow between primary and concomitant fibromyalgia patients: a possible way to differentiate concomitant fibromyalgia from the primary disease |
Search more.